Articles tagged "Liver transplantation"

2019 American Transplant Congress
Preoperative Risk Factor-based Cardiac Catheterization Is Associated With Low Cardiac Morbidity And Mortality In Liver Transplant Patients
R. Rachwan¹, I. Kutkut¹, P. D. Bourdillon², L. R. Timsina³, M. Ghabril⁴, C. A. Kubal⁵, M. A. Lacerda⁶, R. S. Mangus⁵
¹Internal Medicine, Indiana University, Indianapolis, IN, ²Internal Medicine, Indiana University, Division of Cardiology, Indianapolis, IN, ³Department of Biostatistics, Indiana University, Indianapolis, IN, ⁴Internal Medicine, Indiana University, Division of Hepatology, Indianapolis, IN, ⁵Surgery, Transplant Division, Indiana University, Indianapolis, IN, ⁶Internal Medicine, Division of Hepatology, Indiana University, Indianapolis, IN
*Purpose: Mortality post-liver transplant historically was largely attributed to coronary artery disease (CAD). Current guidelines recommend screening with non-invasive modalities in patients with risk factors.…
2019 American Transplant Congress
Impact of Vancomycin-Resistant Enterococci Gut Colonization on Liver Transplant Outcomes
D. Chiang, T. C. Dingle, S. Belga, D. Kabbani, J. Walter, J. G. Abraldes, C. Cervera
University of Alberta, Edmonton, AB, Canada
*Purpose: Vancomycin-resistant enterococci (VRE) colonization is common in liver transplant candidates. In addition to the risk of invasive enterococcal infections, dominance of VRE colonization in…
2019 American Transplant Congress
Early Cognitive Improvement One Month after Liver Transplant Measured by the NIH Toolbox
M. Kim¹, J. D. Peipert², K. J. Reid¹, E. M. Liotta¹, M. B. Maas¹, D. R. Ganger³, P. C. Zee¹, D. P. Ladner⁴
¹Neurology, Northwestern University, Chicago, IL, ²Medical Social Sciences, Northwestern University, Chicago, IL, ³Medicine, Northwestern University, Chicago, IL, ⁴Surgery, Northwestern University, Chicago, IL
*Purpose: Cognitive impairment (CI) is highly prevalent in liver cirrhosis. Improvement after liver transplant (LT) varies among patients, diminishing the benefits of LT for some.…
2019 American Transplant Congress
Bile Duct Anastomosis over Intraluminal Plastic Biliary Stent in Liver Transplant: Clinical Outcome
H. Samant¹, K. Patel¹, W. Manatsathit², N. Singh¹, H. S. Amiri³, G. Zibari³
¹Louisiana State University and Health Science Center, Shreveport, LA, ²University of Nebraska Meical Center, Omaha, NE, ³John C McDonald Transplant Center, Shreveport, LA
*Purpose: Biliary complications have been known as “Achilles Heel” of orthotropic liver transplantation (OLT) with high morbidity and mortality. Intra-luminal plastic biliary stents replacing T-tubes…
2019 American Transplant Congress
Ikaros/IRF4 Signaling Regulates SIRT1-Mediated Macrophage M2 Shift in Liver Ischemia-Reperfusion Injury: From Mouse-to-Human
K. Kadono¹, K. Nakamura¹, H. Hirao¹, S. Kageyama¹, K. J. Dery¹, T. Ito¹, J. Aziz¹, X. Li², B. Ke¹, R. W. Busuttil¹, J. W. Kupiec‐Weglinski¹
¹Dumont-UCLA Transplant Center, UCLA, Los Angeles, CA, ²NIEHS, Durham, NC
*Purpose: Hepatic ischemia-reperfusion injury (IRI) represents a risk factor for early graft dysfunction and rejection in liver transplantation (LT). Despite the efficacy of Sirtuin 1…
2019 American Transplant Congress
The Feasibility Of Donation After Cardiac Death In Liver Transplantation: A Registry Analysis
A. C. Gruessner, R. Misawa, A. Masi, Z. Moghadamyeghaneh, J. F. Renz, R. W. Gruessner
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: Utilization of liver allografts from donation after cardiac death (DCD) has gradually increased in the United States. We aimed to analyze overall utilization of…
2019 American Transplant Congress
Passive Veno-venous Bypass Instead Of Centrifugal Pump Is Feasible And Low Cost For Experimental Pig Liver Transplant
J. A. Kalil, M. Sanchez-Galvez, M. Hertl, E. Schadde
Surgery, Rush University Medical Center, Chicago, IL
*Purpose: Historically, veno-venous bypass centrifugal pumps are often used to complete OLT; here, we describe a simplified method of passive veno-venous bypass in landrace pigs…
2019 American Transplant Congress
Favorable Outcome of Pathologic Downstaging by Locoregional Treatment for Hepatocellular Carcinoma in Liver Transplantation
D. Kim, J. Lee, S. Kim, K. In, D. Joo, S. Kim, M. Kim
Severance hospital, Seoul, Korea, Republic of
*Purpose: There was no distinct guideline how to take into account the effect of pretransplant locoregional treatment (LRT) in hepatocellular carcinoma (HCC) staging system. The…
2019 American Transplant Congress
Excellent Outcomes in Liver Transplantation under Charity Care: An Opportunity to Mitigate Socio-Economic Disparities in Access to Transplantation
F. Paterno¹, J. Rosado¹, R. Olivo², S. Gavzy¹, L. Brown¹, D. Wilson¹, B. Koneru¹, N. Pyrsopoulos², J. V. Guarrera¹
¹Department of Surgery, Division of Transplant and Hepatobiliary Surgery, Rutgers New Jersey Medical School, Newark, NJ, ²Department of Medicine, Division of Hepatology, Rutgers New Jersey Medical School, Newark, NJ
*Purpose: Lack of health insurance is a major barrier in the access to health care even in the case of life-threatening conditions like end-stage liver…
2019 American Transplant Congress
Identification of Adult Liver Transplant Recipients Eligible to Participate in an Immunosuppression Withdrawal Trial Employing Non-Invasive Assessments of Allograft Status
J. Vionnet¹, R. Miquel¹, A. Douiri¹, M. Elstad¹, E. Kodela¹, A. Quaglia², J. Wall¹, P. Ruiz Martin¹, E. B. Riani³, J. Leithead⁴, A. Marshall², M. Navasa⁵, P. Ruiz⁵, J. Ferguson⁶, K. Simpson⁷, A. Pascher⁸, E. Jaeckel⁹, R. Bishop¹⁰, F. Nevens¹¹, S. Masson¹², A. Sanchez-Fueyo¹
¹King's College London, London, United Kingdom, ²Royal Free, London, United Kingdom, ³St-Luc, Brussels, Belgium, ⁴Addenbrookes, Cambridge, United Kingdom, ⁵Hospital Clinic, Barcelona, Spain, ⁶Queen Elizabeth, Birmingham, United Kingdom, ⁷Royal Infirmary, Edinburgh, United Kingdom, ⁸Charité, Berlin, Germany, ⁹Hannover Medical School, Hannover, Germany, ¹⁰Leeds NHS Trust, Leeds, United Kingdom, ¹¹UZ Leuven, Leuven, Belgium, ¹²Hepatology, Newcastle, United Kingdom
*Purpose: Liver Immunosuppression Free Trial (LIFT) is a multicentre international prospective randomised controlled trial of biomarker-guided immunosuppression withdrawal in adult liver transplant recipients who meet…